Inhalable nanocatchers for SARS-CoV-2 inhibition
SARS-CoV-2 억제를 위한 흡입 가능한 나노캐처
422
[키워드] ACE2
acute respiratory syndrome
angiotensin
binding
binding affinity
caused
Cell
cellular membrane
Clinical use
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 epidemic
D614G variant
develop
Efficacy
exhibit
exhibited
exhibiting
expressing
hACE2
hACE2-containing nanocatchers
Health
Health crisis
host cell
host cells
human Angiotensin-converting enzyme
human cell
human cells
Hyaluronic acid
Infection
inhalation
inhibit SARS-CoV-2
lead
lung
lyophilized formulation
mucoadhesive
mutated
mutations
neutralization ability
organ
pandemic
Prevent
PROTECT
Protein
pseudovirus
pseudoviruses
raised
receptors
respiratory
retention
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 variant
SARS-CoV-2 variants
Severe acute respiratory syndrome
Side effects
Significance
significantly
spike glycoprotein
strain
transmission of SARS-CoV-2
Treatment
Vaccine
Viral
Viral mutations
virus
virus inhibitor
viruses
wild-type SARS-CoV-2
[DOI] 10.1073/pnas.2102957118 PMC 바로가기 [Article Type] 422
[DOI] 10.1073/pnas.2102957118 PMC 바로가기 [Article Type] 422